FrancophonIA/ELRC3.0 huggingface dataset:
English: The syringe should be kept upright to avoid leakage and the end of the syringe should not be allowed to contact anything.
Slovenian: Injekcijsko brizgo držite pokonci, da se izognete iztekanju, pri čemer se s konico injekcijske brizge ne dotikajte ničesar.
English: • Abnormal sense of taste, migraine.
Slovenian: • nenormalno okušanje, migrena
English: Shaking can destroy the medicine and create foam.
Slovenian: S stresanjem lahko zdravilo uničite in povzročite penjenje.
English: • Push the needle through the centre of vial stopper, as shown.
Slovenian: • Iglo zabodite skozi sredino zamaška viale, kot kaže slika.
English: Musculoskeletal and connective tissue disorders arthralgia myalgia, arthritis
Slovenian: Bolezni mišičnoskeletnega sistema in vezivnega tkiva artralgija mialgija, artritis
English: 10 vials of powder
Slovenian: 10 vial s praškom
English: General disorders and administration site conditions injection site reaction (including injection site hypersensitivity), injection site bruising or bleeding, injection site hypertrophy (e.g. lipohypertro phy)
Slovenian: Splošne težave in spremembe na mestu aplikacije reakcija na mestu injiciranja (vključno s preobčutljivostjo na mestu injiciranja), podplutbe ali krvavitev na mestu injiciranja, hipertrofija na mestu injiciranja (npr. lipohipertrofija)
English: The development of isolated low-titre anti-growth hormone antibodies was observed in 16.9% of patients treated with pegvisomant.
Slovenian: Pri 16,9 % bolnikov, zdravljenih s pegvisomantom, so ugotovili pojav nizkega titra izoliranih protiteles proti rastnemu hormonu.
English: Dispose
Slovenian: Zavrzite
English: • A suitable sharps container.
Slovenian: • ustrezen vsebnik za odstranjevanje ostrih predmetov.
English: A starting dose of 80 mg of pegvisomant will be given subcutaneously (just under the skin) by your doctor.
Slovenian: Začetni odmerek 80 mg pegvisomanta vam bo zdravnik dal subkutano (tik pod kožo).
English: • May continue therapy with SOMAVERT.
Slovenian: • Lahko nadaljujete zdravljenje z zdravilom SOMAVERT.
English: Blood and lymphatic system disorders thrombocytopenia, leukopenia, leukocytosis, haemorrhagic diathesis
Slovenian: Bolezni krvi in limfatičnega sistema trombocitopenija, levkopenija, levkocitoza, hemoragična diateza
English: • Allow the injection area to dry.
Slovenian: • Pustite, da se koža na mestu injiciranja posuši.
English: - The other ingredients are glycine, mannitol (E421), disodium phosphate anhydrous and sodium dihydrogen phosphate monohydrate.
Slovenian: Pomožne snovi so glicin, manitol (E421), brezvodni natrijev hidrogenfosfat in natrijev dihidrogenfosfat monohidrat.
English: • Gently apply pressure using a hard surface to lock the needle guard in place.
Slovenian: • Nežno jo pritisnite ob trdo površino, da se varovalni nastavek za iglo zaskoči.
English: Table A: Recommendations for initiation of SOMAVERT treatment based on baseline LTs and for periodic monitoring of LTs during SOMAVERT treatment
Slovenian: Preglednica A: Priporočila za uvedbo zdravljenja z zdravilom SOMAVERT na podlagi izhodiščnih vrednosti jetrnih testov in redno spremljanje jetrnih testov med zdravljenjem z zdravilom SOMAVERT
English: Before attaching the supplied safety needle the syringe cap will need to be removed from the pre-filled syringe.
Slovenian: Preden pritrdite priloženo iglo z varovalom, morate z napolnjene injekcijske brizge odstraniti pokrovček.
English: SOMAVERT 10 mg and 15 mg Pack size of 30 vials, pre-filled syringes and safety needles.
Slovenian: SOMAVERT 10 mg in 15 mg Velikost pakiranja po 30 vial, napolnjenih injekcijskih brizg in igel z varovalom.
English: Nervous system disorders headache somnolence, tremor, dizziness, hypoaesthesia narcolepsy, migraine, dysgeusia
Slovenian: Bolezni živčevja glavobol somnolenca, tremor, omotica, hipestezija narkolepsija, migrena, motnje okušanja
English: Inject medicine
Slovenian: Injicirajte zdravilo
English: • Support both the syringe and vial in one hand, as shown.
Slovenian: • Držite injekcijsko brizgo in vialo v eni roki, kot kaže slika.
English: • Fold the needle guard out of the way of the needle cover.
Slovenian: • Upognite varovalni nastavek stran od pokrovčka igle.
English: Immune system disorders hypersensitivity reactionsb anaphylactic reactionb, anaphylactoid reactionb
Slovenian: Bolezni imunskega sistema preobčutljivostne reakcije anafilaktična reakcija b, anafilaktoidna reakcija
English: After single subcutaneous pegvisomant administration no linearity is observed with rising doses of 10, 15 or 20 mg.
Slovenian: Po posamični subkutani uporabi pegvisomanta z naraščajočimi odmerki 10, 15 in 20 mg niso opazili nobene linearnosti.
English: • Pull the needle down so that the needle tip is at the lowest point in the liquid.
Slovenian: • Iglo povlecite navzdol tako, da je njena konica na najnižji točki v tekočini.
English: • Serum concentrations of ALT and AST should be monitored at 4- to 6-week intervals for the first 6 months of treatment with SOMAVERT, or at any time in patients exhibiting symptoms suggestive of hepatitis.
Slovenian: • Prvih 6 mesecev zdravljenja z zdravilom SOMAVERT je treba na 4 do 6 tednov spremljati koncentraciji ALT in AST v serumu.
English: Systemic hypersensitivity reactions including anaphylactic/anaphylactoid reactions, laryngospasm, angioedema, generalized skin reactions (rash, erythema, pruritus, urticaria).have been reported in post marketing use.
Slovenian: V obdobju trženja so poročali o sistemskih preobčutljivostnih reakcijah, vključno z anafilaktičnimi/anafilaktoidnimi reakcijami, laringospazmom, angioedemom, generaliziranimi kožnimi reakcijami (izpuščaj, eritem, pruritus, urtikarija).
English: After preparing the SOMAVERT solution it must be used immediately.
Slovenian: Raztopino zdravila SOMAVERT je treba uporabiti takoj po pripravi.
English: Mild to serious allergic (anaphylactic) reactions have been reported in some patients taking SOMAVERT.
Slovenian: Pri nekaterih bolnikih, ki so uporabljali zdravilo SOMAVERT, so poročali o blagih do hudih alergijskih (anafilaktičnih) reakcijah.
English: ALT or AST elevations
Slovenian: Zvečanje koncentracije ALT ali AST
English: • All questions should be handled by a doctor, nurse or pharmacist familiar with SOMAVERT.
Slovenian: • O vseh vprašanjih se posvetujte z zdravnikom, medicinsko sestro ali farmacevtom, ki zdravilo
English: The active substance in SOMAVERT, pegvisomant is known as a growth hormone receptor antagonist.
Slovenian: Učinkovina v zdravilu SOMAVERT je pegvisomant, ki je antagonist receptorjev za rastni hormon.
English: Gastrointestinal disorders diarrhoea vomiting, constipation, nausea, abdominal distension, dyspepsia, flatulence haemorrhoids, salivary hypersecretion, dry mouth, tooth disorder
Slovenian: Bolezni prebavil diareja bruhanje, zaprtje, navzea, napihnjenost trebuha, dispepsija, flatulenca hemoroidi, čezmerno izločanje sline, suha usta, bolezni zob
English: Note: If you see air in the syringe, tap the barrel to float the bubbles to the top,and then gently push the bubbles out into the vial.
Slovenian: Opomba: če so v brizgi mehurčki (zrak), potrkajte po njej, da se dvignejo na gladino, nato pa jih previdno iztisnite nazaj v vialo.
English: • May treat with SOMAVERT.
Slovenian: • Lahko zdravite z zdravilom SOMAVERT.
English: • Support the syringe while the needle is in the vial stopper to prevent bending the needle.
Slovenian: • Ko je igla v zamašku, držite injekcijsko brizgo, da preprečite zvijanje igle.
English: • Fold the needle guard over the needle.
Slovenian: • Upognite varovalni nastavek čez iglo.
English: Increased fertility
Slovenian: Zvečana plodnost
English: Keep the powder vials in their outer carton in order to protect from light.
Slovenian: Viale s praškom shranjujte v njihovi zunanji ovojnini za zagotovitev zaščite pred svetlobo.
English: The mean IGF-I concentration in this cohort fell from 917 ng/ml to 299 ng/ml on pegvisomant, with 92% achieving a normal (age-adjusted) IGF-I concentration.
Slovenian: 299 ng/ml; 92 % preskušancev je doseglo normalno koncentracijo IGF-I (tj. koncentracijo v ustreznem območju za starost).
English: Solvent for SOMAVERT SC
Slovenian: Vehikel za zdravilo SOMAVERT s.c.
English: Metabolism and nutrition disorders hypercholesterol aemia, hyperglycaemia, hypoglycaemia, weight increased hypertriglyceridemia
Slovenian: Presnovne in prehranske motnje hiperholesterolemija, hiperglikemija, hipoglikemija, zvečanje telesne mase hipertrigliceridemija
English: • Push the plunger rod down slowly until all the liquid has emptied into the vial.
Slovenian: • Bat počasi potiskajte navzdol, dokler ne izpraznite vse tekočine v vialo.
English: You must mix Somavert with a liquid (diluent) before you can use it.
Slovenian: Pred uporabo je treba zdravilo Somavert zmešati s tekočino (vehiklom).
English: If air is seen in the syringe, tap the barrel to float the bubbles to the top, and then gently push the bubbles out into the vial.
Slovenian: Če so v brizgi mehurčki (zrak), potrkajte po njej, da se dvignejo na gladino, nato pa jih previdno iztisnite nazaj v vialo.
English: Store the powder vial(s) in a refrigerator.
Slovenian: Viale s praškom shranjujte v hladilniku.
English: Store the powder vial(s) in a refrigerator (2C - 8C).
Slovenian: Viale s praškom shranjujte v hladilniku (2 C - 8 C).
English: • Peel open the packaging of the syringe and safety needle to make it easier to pick up each item as you prepare for your injection.
Slovenian: • Odprite zunanja ovoja injekcijske brizge in igle z varovalom, da vam bosta oba predmeta med pripravo na injiciranje pri roki.
English: 30 pre-filled syringes of solvent 30 injection needles
Slovenian: 30 napolnjenih injekcijskih brizg z vehiklom 30 injekcijskih igel
English: PHARMACEUTICAL FORM Powder and solvent for solution for injection (powder for injection).
Slovenian: prašek in vehikel za raztopino za injiciranje (prašek za injiciranje)
English: Pegvisomant treatment should therefore not be monitored or adjusted based on serum growth hormone concentrations reported from these assays.
Slovenian: Komercialni testi za določanje koncentracije rastnega hormona posledično dajejo napačne rezultate in zato se zdravljenja s pegvisomantom ne sme nadzirati ali prilagajati glede na serumsko koncentracijo rastnega hormona, izmerjeno s takšnimi testi.
English: • A vial of Somavert powder.
Slovenian: • vialo s praškom zdravila Somavert,
English: • Carefully pull the needle cover straight off.
Slovenian: • Z ravnim potegom previdno odstranite pokrovček igle.
English: • Gently swirl the liquid, sliding the vial in a circular motion on a flat surface.
Slovenian: • Previdno zmešajte tekočino, tako da z vialo krožite po ravni površini.
English: In the event of either being observed, discard the medicinal product..
Slovenian: Če opazite kaj od naštetega, zdravilo zavrzite.
English: Powder:
Slovenian: Trebuh:
English: Administration of pegvisomant should be discontinued if signs of liver disease persist.
Slovenian: Če znaki bolezni jeter vztrajajo, je treba uporabo pegvisomanta prekiniti.
English: Store the pre-filled syringe(s) below 30C or store in a refrigerator.
Slovenian: Napolnjene injekcijske brizge shranjujte pri temperaturi do 30 °C ali v hladilniku.
English: Note: You will hear a click when the needle guard has been locked.
Slovenian: • Opomba: Ko se varovalni nastavek za iglo zaskoči, boste zaslišali klik.
English: The solvent should be emptied into the vial slowly to avoid the possibility of a foam forming.
Slovenian: Vehikel izpraznite v vialo počasi, da se izognete penjenju, ki naredi zdravilo neuporabno.
English: QUESTIONS & ANSWERS What should I do if anything has accidentally touched the vial stopper?
Slovenian: Kaj naj storim, če se z zamaškom viale pomotoma nečesa dotaknem?
English: • Dizziness, sleepiness, uncontrolled trembling, decreased sense of touch.
Slovenian: • omotica, bolezenska zaspanost, nehotno tresenje, zmanjšana občutljivost na dotik
English: • Sweating, itching, rash, tendency to bruise.
Slovenian: • znojenje, srbenje, izpuščaj, nagnjenost k podplutbam
English: SOMAVERT 10 mg powder and solvent for solution for injection SOMAVERT 15 mg powder and solvent for solution for injection SOMAVERT 20 mg powder and solvent for solution for injection SOMAVERT 25 mg powder and solvent for solution for injection SOMAVERT 30 mg powder and solvent for solution for injection
Slovenian: SOMAVERT 10 mg prašek in vehikel za raztopino za injiciranje SOMAVERT 15 mg prašek in vehikel za raztopino za injiciranje SOMAVERT 20 mg prašek in vehikel za raztopino za injiciranje SOMAVERT 25 mg prašek in vehikel za raztopino za injiciranje SOMAVERT 30 mg prašek in vehikel za raztopino za injiciranje
English: SOMAVERT 10 mg powder and solvent for solution for injection SOMAVERT 15 mg powder and solvent for solution for injection SOMAVERT 20 mg powder and solvent for solution for injection SOMAVERT 25 mg powder and solvent for solution for injection SOMAVERT 30 mg powder and solvent for solution for injection pegvisomant
Slovenian: SOMAVERT 10 mg prašek in vehikel za raztopino za injiciranje SOMAVERT 15 mg prašek in vehikel za raztopino za injiciranje SOMAVERT 20 mg prašek in vehikel za raztopino za injiciranje SOMAVERT 25 mg prašek in vehikel za raztopino za injiciranje SOMAVERT 30 mg prašek in vehikel za raztopino za injiciranje pegvisomant
English: Respiratory, thoracic and mediastinal disorders dyspnoea laryngospasmb
Slovenian: Bolezni dihal, prsnega koša in mediastinalnega prostora dispneja laringospazem
English: Store the pre-filled syringe(s) below 30C or store in a refrigerator (2C - 8C).
Slovenian: Napolnjene injekcijske brizge shranjujte pri temperaturi do 30 C ali v hladilniku (2 C - 8 C).
English: • Eyestrain, inner ear problems.
Slovenian: • naprezanje oči, težave z notranjim ušesom
English: Pegvisomant has significant structural similarity to growth hormone which causes it to cross-react in commercially available growth hormone assays.
Slovenian: Pegvisomant je po strukturi močno podoben rastnemu hormonu, zato navzkrižno reagira s komercialnimi testi za določanje tega hormona.
English: The safety and efficacy of SOMAVERT in patients with renal or hepatic insufficiency has not been established.
Slovenian: Okvara jeter ali ledvic Pri bolnikih z okvaro ledvic ali jeter varnost in učinkovitost zdravila SOMAVERT nista bili dokazani.
English: Remove syringe cap
Slovenian: Odstranite pokrovček brizge
English: Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http://www.ema.europa.eu.
Slovenian: Podrobne informacije o zdravilu so objavljene na spletni strani Evropske agencije za zdravila http://www.ema.europa.eu, kjer so na voljo tudi povezave do drugih spletnih strani o redkih boleznih in zdravljenju.
English: Remove needle cover
Slovenian: Odstranite pokrovček igle
English: 1 pre-filled syringe of solvent 1 injection needle
Slovenian: 1 napolnjena injekcijska brizga z vehiklom 1 injekcijska igla
English: After reconstitution, the product should be used immediately.
Slovenian: Zdravilo je treba uporabiti takoj po pripravi.
English: Caution: Do not let the end of the syringe touch anything when the syringe cap is off.
Slovenian: Pozor: Ko je pokrovček brizge odstranjen, se s konico injekcijske brizge ne dotikajte ničesar.
English: Administration of SOMAVERT should be discontinued if signs of liver disease persist.
Slovenian: Če znaki bolezni jeter trajajo, je treba zdravljenje z zdravilom SOMAVERT prekiniti.
English: Store the pre-filled syringe(s) below 30C or store in a refrigerator (2ºC - 8°C).
Slovenian: Napolnjene injekcijske brizge shranjujte pri temperaturi do 30 °C ali v hladilniku (2 °C - 8 °C).
English: Evidence of obstructive biliary tract disease should be ruled out in patients with elevations of ALT and AST or in patients with a prior history of treatment with any somatostatin analogue.
Slovenian: Pri bolnikih z zvečanimi vrednostmi ALT in AST oz. bolnikih, ki so se že zdravili s kakšnim analogom somatostatina, je treba izključiti obstruktivno bolezen biliarnega trakta.
English: SOMAVERT is used for the treatment of acromegaly, a hormonal disorder resulting from the increased secretion of growth hormone (GH) and IGF-I (Insulin-like growth factors), which is characterised by overgrowth of bone, soft tissue swelling, heart disease and related disorders.
Slovenian: Akromegalija je hormonska motnja, ki nastane zaradi zvečanega izločanja rastnega hormona in IGF-I (insulinu podobnih rastnih dejavnikov).
English: Eye disorders eye pain asthenopia
Slovenian: Očesne bolezni bolečina v očeh astenopija
English: • Keeping the needle in the vial, look carefully at the medicine.
Slovenian: • Previdno preglejte zdravilo, medtem pa naj igla ostane v viali.
English: • Remove the cap from the vial.
Slovenian: • Z viale odstranite zaporko.
English: The metabolism of pegvisomant has not been studied.
Slovenian: Presnova pegvisomanta ni raziskana.
English: SOMAVERT contains sodium
Slovenian: Kaj vsebuje zdravilo SOMAVERT
English: SOMAVERT 20 mg, 25 mg and 30 mg Pack sizes of 1 and 30 vial(s), pre-filled syringe(s) and safety needle(s) Not all pack sizes may be marketed.
Slovenian: SOMAVERT 20 mg, 25 mg in 30 mg Velikost pakiranja po 1 in 30 vial, napolnjenih injekcijskih brizg in igel z varovalom.
English: The 25 mg strength of the medicinal product contains 0.5 mg of sodium per vial of powder.
Slovenian: Ena viala zdravila z jakostjo 25 mg vsebuje 0,5 mg natrija.
English: Interaction with other medicinal products and other forms of interaction No interaction studies have been performed.
Slovenian: 4.5 Medsebojno delovanje z drugimi zdravili in druge oblike interakcij
English: - SOMAVERT 20 mg: One vial of powder contains 20 mg pegvisomant.
Slovenian: SOMAVERT 20 mg: Ena viala s praškom vsebuje 20 mg pegvisomanta.
English: Skin and subcutaneous tissue disorders hyperhidrosis, contusion, pruritusb, rashb face oedema, dry skin, increased tendency to bruise, night sweats, erythema b, urticaria b angioedemab
Slovenian: izpuščaj edem obraza, suha koža, nagnjenost k podplutbam, nočno znojenje, eritem b,
English: Growth hormone-secreting tumours
Slovenian: Tumorji, ki izločajo rastni hormon
English: - SOMAVERT 25 mg: One vial of powder contains 25 mg pegvisomant.
Slovenian: SOMAVERT 25 mg: Ena viala s praškom vsebuje 25 mg pegvisomanta.
English: Fertility, pregnancy and lactation Women of childbearing potential
Slovenian: 4.6 Plodnost, nosečnost in dojenje
English: Disodium phosphate anhydrous Sodium dihydrogen phosphate monohydrate Water for Injections
Slovenian: glicin manitol (E421) brezvodni natrijev hidrogenfosfat natrijev dihidrogenfosfat monohidrat voda za injekcije
English: Fatty tissue of the skin can build-up at the site of injection.
Slovenian: Na mestu injiciranja se lahko poveča količina maščobnega tkiva.
English: - SOMAVERT 30 mg: One vial of powder contains 30 mg pegvisomant.
Slovenian: SOMAVERT 30 mg: Ena viala s praškom vsebuje 30 mg pegvisomanta.
English: Warnings and precautions Talk to your doctor, pharmacist or nurse before using SOMAVERT.
Slovenian: Pred začetkom jemanja zdravila SOMAVERT se posvetujte z zdravnikom, farmacevtom ali medicinsko sestro.
English: The site of injection should be rotated daily to help prevent lipohypertrophy.
Slovenian: Za preprečitev lipohipertrofije je treba zdravilo vsak dan injicirati na drugo mesto.
English: • Bruising or bleeding at injection site, soreness or swelling at injection site, build up of fat below the surface of the skin at injection site, swelling of the extremities, weakness, fever.
Slovenian: • podplutba ali krvavitev na mestu injiciranja, bolečina ali oteklina na mestu injiciranja,
English: Always inject this medicine exactly as your doctor or pharmacist has told you.
Slovenian: Pri injiciranju tega zdravila natančno upoštevajte navodila zdravnika ali farmacevta.
English: The 15 mg strength of the medicinal product contains 0.4 mg of sodium per vial of powder.
Slovenian: Ena viala zdravila z jakostjo 15 mg vsebuje 0,4 mg natrija.
English: POWDER VIAL
Slovenian: Odstranite zaporko viale
English: Posology
Slovenian: Predpriprava
English: SOMAVERT 20 mg powder and solvent for solution for injection One vial contains 20 mg of pegvisomant.
Slovenian: SOMAVERT 20 mg prašek in vehikel za raztopino za injiciranje Ena viala vsebuje 20 mg pegvisomanta.
English: - If you get any side effects, talk to your doctor, pharmacist or nurse.
Slovenian: • Če opazite katerikoli neželeni učinek, se posvetujte z zdravnikom ali farmacevtom ali medicinsko sestro.
English: Renal and urinary disorders haematuria proteinuria, polyuria, renal impairment
Slovenian: Bolezni sečil hematurija proteinurija, poliurija, okvara ledvic
English: • Eye pain
Slovenian: • bolečina v očeh
English: - Your doctor will conduct tests of your liver function before starting and during treatment with SOMAVERT.
Slovenian: Pred začetkom zdravljenja z zdravilom SOMAVERT in med njim bo zdravnik opravil teste delovanja vaših jeter.
English: Malignant fibrous histiocytomas associated with fibrosis and histiocytic inflammation were observed at injection sites in males in the rat carcinogenicity study at exposure levels equivalent to three times the human exposure based on mean plasma concentrations in two long-term studies at a daily dose of 30 mg.
Slovenian: V dveh dolgoročnih študijah kancerogenosti pri podganjih samcih so na mestih injiciranja opazili maligni fibrozni histiocitom, povezan s fibrozo in histiocitnim vnetjem.
English: - SOMAVERT 10 mg: One vial of powder contains 10 mg pegvisomant.
Slovenian: SOMAVERT 10 mg: Ena viala s praškom vsebuje 10 mg pegvisomanta.
English: PHARMACOLOGICAL PROPERTIES 5.1.
Slovenian: 5.1 Farmakodinamične lastnosti
English: - SOMAVERT 15 mg: One vial of powder contains 15 mg pegvisomant.
Slovenian: SOMAVERT 15 mg: Ena viala s praškom vsebuje 15 mg pegvisomanta.
English: • Feeling abnormal, impaired healing.
Slovenian: • nenormalno počutje, počasnejše celjenje
English: where it blocks growth hormone binding, and thus interferes with intracellular growth hormone signal transduction.
Slovenian: Pegvisomant se veže na receptorje za rastni hormon na površini celic, s tem prepreči vezavo rastnega hormona in tako ovira znotrajcelični prenos signalov rastnega hormona.
English: • Gently pinch the skin at the site of injection.
Slovenian: • Kožo na mestu injiciranja rahlo stisnite v gubo.
English: Excipient with known effect The 30 mg strength of the medicinal product contains 0.6 mg of sodium per vial of powder.
Slovenian: Ena viala zdravila z jakostjo 30 mg vsebuje 0,6 mg natrija.
English: SOMAVERT 25 mg powder and solvent for solution for injection One vial contains 25 mg of pegvisomant.
Slovenian: SOMAVERT 25 mg prašek in vehikel za raztopino za injiciranje Ena viala vsebuje 25 mg pegvisomanta.
English: • Discontinue SOMAVERT immediately.
Slovenian: • Takoj prekinite zdravljenje z zdravilom SOMAVERT.
English: • Tilt both the vial and syringe at an angle, as shown.
Slovenian: • Nagnite vialo in injekcijsko brizgo pod kotom, kot kaže slika.
English: SOMAVERT 30 mg powder and solvent for solution for injection One vial contains 30 mg of pegvisomant.
Slovenian: SOMAVERT 30 mg prašek in vehikel za raztopino za injiciranje Ena viala vsebuje 30 mg pegvisomanta.
English: Keep the vial(s) in their outer carton in order to protect from light.
Slovenian: Viale shranjujte v njihovi zunanji ovojnini za zagotovitev zaščite pred svetlobo.
English: • Do not rub the area.
Slovenian: • Predela ne masirajte.
English: Keep out of reach of children.
Slovenian: Zdravilo shranjujte nedosegljivo otrokom!
English: SOMAVERT 15 mg powder and solvent for solution for injection One vial contains 15 mg of pegvisomant.
Slovenian: SOMAVERT 15 mg prašek in vehikel za raztopino za injiciranje Ena viala vsebuje 15 mg pegvisomanta.
English: SOMAVERT 10 mg powder and solvent for solution for injection One vial contains 10 mg of pegvisomant.
Slovenian: SOMAVERT 10 mg prašek in vehikel za raztopino za injiciranje Ena viala vsebuje 10 mg pegvisomanta.
English: Disodium phosphate anhydrous Sodium dihydrogen phosphate monohydrate
Slovenian: glicin manitol (E421) brezvodni natrijev hidrogenfosfat natrijev dihidrogenfosfat monohidrat